Epidermal growth factor and transforming growth factor-alpha stimulate the proliferation of mouse uterine stromal cells.
Growth factors produced in the uterine endometrium are considered to be involved in the proliferation of the mouse uterine stromal cells induced by estradiol-17beta (E(2)) and progesterone (P). The effect of epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-alpha), one of EGF-related growth factors, on the proliferation of mouse uterine stromal cells was studied in a serum-free culture. The growth of the uterine stromal cells was measured by MTT assay. EGF was found to increase the number of uterine stromal cells in a dose-dependent manner. The DNA-replicating cells were investigated using the immunocytochemical detection of bromodeoxyuridine (BrdU)-labeled cells. EGF and TGF-alpha increased the percentage of BrdU-labeled cells in a dose-dependent manner. Administration of the combination of E(2) (10(-9) M) and P (10(-7) M) for 2 days increased the percentage of BrdU-labeled cells 2.3-fold. The stimulatory effect of EGF, TGF-alpha and the combination of E(2) and P on DNA replication in the uterine stromal cells was repressed by RG-13022 (10(-5) M, the inhibitor of the EGF receptor tyrosine kinase). RT-PCR analysis of EGF-receptor-, TGF-alpha-, and EGF-mRNA was carried out in the cultured uterine stromal cells, and revealed the expression of those mRNAs. These data supported the hypothesis that uterine endometrial stromal growth induced by sex steroids required the EGF family of ligands such as EGF and TGF-alpha, both produced in the stromal cells, acting for DNA synthesis through EGF receptors.
Komatsu
Noriko
N
Department of Biology, Faculty of Science, Okayama University, Okayama, Japan.
Maekawa
Tetsuya
T
Takeuchi
Sakae
S
Takahashi
Sumio
S
D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured / Q000187:drug effects; D017931:DNA Primers; D018076:DNA, Complementary / Q000032:analysis / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004717:Endometrium / Q000166:cytology*; D004815:Epidermal Growth Factor / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D051379:Mice; D008813:Mice, Inbred ICR; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013268:Stimulation, Chemical; D017154:Stromal Cells / Q000187:drug effects*; D016211:Transforming Growth Factor alpha / Q000008:administration & dosage / Q000494:pharmacology*
D017931:DNA Primers; D018076:DNA, Complementary; D016211:Transforming Growth Factor alpha; D004815:Epidermal Growth Factor